Microbiome medicine accelerated by new partnership between BiomeBank and Hudson Institute

• BiomeBank and Hudson Institute sign a 4-year collaboration agreement to discover and develop microbial therapies. • BiomeBank gains exclusive license to paediatric IBD study, which identified key bacteria believed to be involved in disease onset and resolution. These bacteria were identified using a world-first method that unlocks culturing and metagenomics of colon biopsy samples. The…

0 Comments